These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
607 related items for PubMed ID: 12439841
1. [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)]. Vallero A, Cesano G, Pozzato M, Garbo R, Minelli M, Quarello F, Formica M. G Ital Nefrol; 2002; 19(5):529-33. PubMed ID: 12439841 [Abstract] [Full Text] [Related]
5. Nephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteine. Briguori C, Colombo A, Airoldi F, Morici N, Sangiorgi GM, Violante A, Focaccio A, Montorfano M, Carlino M, Condorelli G, Ricciardelli B. Kidney Int; 2005 Nov; 68(5):2250-5. PubMed ID: 16221226 [Abstract] [Full Text] [Related]
9. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions. Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G. J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692 [Abstract] [Full Text] [Related]
10. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK. Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497 [Abstract] [Full Text] [Related]
11. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention. Seyon RA, Jensen LA, Ferguson IA, Williams RG. Heart Lung; 2007 Nov; 36(3):195-204. PubMed ID: 17509426 [Abstract] [Full Text] [Related]